Bristol-Myers Squibb Company (FRA:BRM)
Germany · Delayed Price · Currency is EUR | Market Cap | 104.85B -9.8% |
| Revenue (ttm) | 41.05B -0.2% |
| Net Income | 6.01B |
| EPS | 2.95 |
| Shares Out | n/a |
| PE Ratio | 17.45 |
| Forward PE | 9.66 |
| Dividend | 2.15 (4.20%) |
| Ex-Dividend Date | Jan 2, 2026 |
| Volume | 112 |
| Average Volume | 609 |
| Open | 50.29 |
| Previous Close | 50.31 |
| Day's Range | 49.98 - 51.32 |
| 52-Week Range | 36.65 - 58.00 |
| Beta | n/a |
| RSI | 61.22 |
| Earnings Date | Feb 5, 2026 |
About FRA:BRM
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat ... [Read more]
News
Vanguard U.S. Multifactor ETF Buys 4,145 Shares of Bristol-Myers Squibb Co (BMY)
Vanguard U.S. Multifactor ETF Buys 4,145 Shares of Bristol-Myers Squibb Co (BMY)
Vanguard Russell 1000 Value Index Fund Buys 6,412 Shares of Bristol-Myers Squibb Co (BMY)
Vanguard Russell 1000 Value Index Fund Buys 6,412 Shares of Bristol-Myers Squibb Co (BMY)
Vanguard U.S. Value Factor ETF Sells 4,222 Shares of Bristol-Myers Squibb Co (BMY)
Vanguard U.S. Value Factor ETF Sells 4,222 Shares of Bristol-Myers Squibb Co (BMY)
Bristol Myers (BMY) Secures FDA Priority Review for Iberdomide
Bristol Myers (BMY) Secures FDA Priority Review for Iberdomide
Bristol Myers wins FDA priority review for multiple myeloma therapy
BLUEPRINT ADAPTIVE GROWTH ALLOCATION FUND Buys 3,035 Shares of Bristol-Myers Squibb Co (BMY)
BLUEPRINT ADAPTIVE GROWTH ALLOCATION FUND Buys 3,035 Shares of Bristol-Myers Squibb Co (BMY)
Xtrackers US National Critical Technologies ETF Buys 117 Shares of Bristol-Myers Squibb Co (BMY)
Xtrackers US National Critical Technologies ETF Buys 117 Shares of Bristol-Myers Squibb Co (BMY)
PGIM Quant Solutions Large-Cap Value Fund Buys 2,900 Shares of Bristol-Myers Squibb Co (BMY)
PGIM Quant Solutions Large-Cap Value Fund Buys 2,900 Shares of Bristol-Myers Squibb Co (BMY)
Avantis U.S. Equity ETF Buys 316,605 Shares of Bristol-Myers Squibb Co (BMY)
Avantis U.S. Equity ETF Buys 316,605 Shares of Bristol-Myers Squibb Co (BMY)
EVERGREEN CAPITAL MANAGEMENT LLC Sells 14,084 Shares of Bristol-Myers Squibb Co (BMY)
EVERGREEN CAPITAL MANAGEMENT LLC Sells 14,084 Shares of Bristol-Myers Squibb Co (BMY)
Avantis Responsible U.S. Equity ETF Buys 116 Shares of Bristol-Myers Squibb Co (BMY)
Avantis Responsible U.S. Equity ETF Buys 116 Shares of Bristol-Myers Squibb Co (BMY)
Bristol Myers (BMY) Receives FDA Orphan Drug Status for Follicular Lymphoma Treatment
Bristol Myers (BMY) Receives FDA Orphan Drug Status for Follicular Lymphoma Treatment
American Century U.S. Quality Growth ETF Sells 50,392 Shares of Bristol-Myers Squibb Co (BMY)
American Century U.S. Quality Growth ETF Sells 50,392 Shares of Bristol-Myers Squibb Co (BMY)
American Century U.S. Quality Value ETF Sells 22,805 Shares of Bristol-Myers Squibb Co (BMY)
American Century U.S. Quality Value ETF Sells 22,805 Shares of Bristol-Myers Squibb Co (BMY)
American Century Large Cap Equity ETF Buys 1,333 Shares of Bristol-Myers Squibb Co (BMY)
American Century Large Cap Equity ETF Buys 1,333 Shares of Bristol-Myers Squibb Co (BMY)
What Does the Market Think About Bristol-Myers Squibb Co?
Bristol-Myers Squibb Co's (NYSE: BMY) short interest as a percent of float has fallen 19.23% since its last report. According to exchange reported data, there are now 29.89 million shares sold short ...
Xtrackers MSCI USA Selection Equity ETF Sells 6,995 Shares of Bristol-Myers Squibb Co (BMY)
Xtrackers MSCI USA Selection Equity ETF Sells 6,995 Shares of Bristol-Myers Squibb Co (BMY)
Xtrackers MSCI Kokusai Equity ETF Buys 124 Shares of Bristol-Myers Squibb Co (BMY)
Xtrackers MSCI Kokusai Equity ETF Buys 124 Shares of Bristol-Myers Squibb Co (BMY)
Xtrackers MSCI USA Climate Action Equity ETF Buys 914 Shares of Bristol-Myers Squibb Co (BMY)
Xtrackers MSCI USA Climate Action Equity ETF Buys 914 Shares of Bristol-Myers Squibb Co (BMY)
Beyond the Balance Sheet: What SWOT Reveals About Bristol-Myers Squibb Co (BMY)
Beyond the Balance Sheet: What SWOT Reveals About Bristol-Myers Squibb Co (BMY)
Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff
Goldman Sachs MarketBeta(R) Russell 1000 Growth Equity ETF Buys 405 Shares of Bristol-Myers ...
Goldman Sachs MarketBeta(R) Russell 1000 Growth Equity ETF Buys 405 Shares of Bristol-Myers Squibb Co (BMY)
Goldman Sachs MarketBeta U.S. 1000 Equity ETF Sells 215 Shares of Bristol-Myers Squibb Co (BMY)
Goldman Sachs MarketBeta U.S. 1000 Equity ETF Sells 215 Shares of Bristol-Myers Squibb Co (BMY)
Goldman Sachs MarketBeta U.S. Equity ETF Buys 3,841 Shares of Bristol-Myers Squibb Co (BMY)
Goldman Sachs MarketBeta U.S. Equity ETF Buys 3,841 Shares of Bristol-Myers Squibb Co (BMY)
Systematic Core Fund Buys 4,075 Shares of Bristol-Myers Squibb Co (BMY)
Systematic Core Fund Buys 4,075 Shares of Bristol-Myers Squibb Co (BMY)